老年心房颤动患者应用华法林的出血风险、影响因素与预防方法

[1] 中国心房颤动现状的流行病学研究 [J]. 中华内科杂志, 2004, (07) : 15 - 18

[2] 心血管疾病防治中国专家共识[M]. 人民卫生出版社 , 胡大一主编, 2006

[3] Antithrombotic therapy in very elderly patients with atrial fibrillation: Is it enough to assess thromboembolic risk?[J] . Yutao Guo.Clinical Interventions in Aging . 2010 (defa)

[4] Bleeding Risk During Oral Anticoagulation in Atrial Fibrillation Patients Older Than 80 Years [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (11) : 999 - 1002

[5] Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation （the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA）: a randomised controlled trial[J] . Jonathan Mant,FD Richard Hobbs,Kate Fletcher,Andrea Roalfe,David Fitzmaurice,Gregory YH Lip,Ellen Murray.The Lancet . 2007 (9586)

[6] Major Hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation [J]. CIRCULATION, 2007, 115 (21) : 2689 - 2696

[7] Development of a contemporary bleeding risk model for elderly warfarin recipients [J]. CHEST, 2006, 130 (05) : 1390 - 1396

[8] Translating the Results of Randomized Trials into Clinical Practice: The Challenge of Warfarin Candidacy Among Hospitalized Elderly Patients With Atrial Fibrillation[J] . Elaine M. Hylek,James D’Antonio,Carmella Evans-Molina,Carol Shea,Lori E. Henault,Susan Regan.Stroke . 2006 (4)

[9] Combined Anticoagulant–Antiplatelet Use and Major Bleeding Events in Elderly Atrial Fibrillation Patients[J] . Theresa I. Shireman,Patricia A. Howard,Timothy F. Kresowik,Edward F. Ellerbeck.Stroke . 2004 (10)

[10] Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (the Framingham heart study) [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (07) : 947 - +

[1] 中国心房颤动现状的流行病学研究 [J]. 中华内科杂志, 2004, (07) : 15 - 18

[2] 心血管疾病防治中国专家共识[M]. 人民卫生出版社 , 胡大一主编, 2006

[3] Antithrombotic therapy in very elderly patients with atrial fibrillation: Is it enough to assess thromboembolic risk?[J] . Yutao Guo.Clinical Interventions in Aging . 2010 (defa)

[4] Bleeding Risk During Oral Anticoagulation in Atrial Fibrillation Patients Older Than 80 Years [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (11) : 999 - 1002

[5] Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation （the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA）: a randomised controlled trial[J] . Jonathan Mant,FD Richard Hobbs,Kate Fletcher,Andrea Roalfe,David Fitzmaurice,Gregory YH Lip,Ellen Murray.The Lancet . 2007 (9586)

[6] Major Hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation [J]. CIRCULATION, 2007, 115 (21) : 2689 - 2696

[7] Development of a contemporary bleeding risk model for elderly warfarin recipients [J]. CHEST, 2006, 130 (05) : 1390 - 1396

[8] Translating the Results of Randomized Trials into Clinical Practice: The Challenge of Warfarin Candidacy Among Hospitalized Elderly Patients With Atrial Fibrillation[J] . Elaine M. Hylek,James D’Antonio,Carmella Evans-Molina,Carol Shea,Lori E. Henault,Susan Regan.Stroke . 2006 (4)

[9] Combined Anticoagulant–Antiplatelet Use and Major Bleeding Events in Elderly Atrial Fibrillation Patients[J] . Theresa I. Shireman,Patricia A. Howard,Timothy F. Kresowik,Edward F. Ellerbeck.Stroke . 2004 (10)

[10] Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (the Framingham heart study) [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (07) : 947 - +